Algenpantucel-L

DB17184InvestigationalVaccines

Algenpantucel-L: Overview.

Also known as
Alpha (1,3) galactosyltransferase tumor vaccine · Alpha-1,3-galactosyltransferase-expressing allogeneic pancreatic tumor cell vaccine · Hyperacute pancreatic cancer vaccine · Hyperacute-pancreas immunotherapy

Resolves to

What you can answer from here — as of April 23, 2025

4Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Algenpantucel-L, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account